Clinical Trial Update: Prevention of Neonatal Respiratory Distress Syndrome With Antenatal Steroid Administration [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating antenatal steroid administration for prevention of neonatal respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Lung Diseases, Respiratory Distress Syndrome | Phase 3 | Status: COMPLETED